Unlock stock picks and a broker-level newsfeed that powers Wall Street.
OTC Markets OTCPK - Delayed Quote USD

NuGen Medical Devices Inc. (NGMDF)

Compare
0.0317
0.0000
(0.00%)
At close: April 3 at 4:00:00 PM EDT
Currency in CAD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
762.7920
331.4030
152.3580
137.6480
47.2950
Cost of Revenue
404.1660
166.5620
53.1900
45.4240
12.9100
Gross Profit
358.6260
164.8410
99.1680
92.2240
34.3850
Operating Expense
6,837.4180
8,205.6470
4,886.6580
7,736.9760
2,645.5650
Operating Income
-6,478.7920
-8,040.8060
-4,787.4900
-7,644.7520
-2,611.1800
Net Non Operating Interest Income Expense
-1,749.8750
-1,236.3030
-860.5850
-1,217.3080
-887.3420
Other Income Expense
-45.3610
-51.3120
73.3280
1,757.9340
-159.7140
Pretax Income
-8,274.0280
-9,328.4210
-5,574.7470
-7,104.1260
-3,658.2360
Tax Provision
36.1840
33.7960
3.1790
2.9560
12.1660
Net Income Common Stockholders
-8,310.2120
-9,362.2170
-5,577.9260
-7,107.0820
-3,670.4020
Diluted NI Available to Com Stockholders
-8,310.2120
-9,362.2170
-5,577.9260
-7,107.0820
-3,670.4020
Basic EPS
-0.04
-0.05
-0.06
-0.10
-0.04
Diluted EPS
-0.04
-0.05
-0.06
-0.10
-0.04
Basic Average Shares
209,338.1660
167,664.9930
90,102.0670
68,674.5020
86,014.9610
Diluted Average Shares
209,338.1660
167,664.9930
90,102.0670
68,674.5020
86,014.9610
Total Operating Income as Reported
-6,486.0400
-8,048.0540
-4,794.0350
-7,671.2970
-2,611.1800
Rent Expense Supplemental
170.0100
111.7150
92.0140
208.3690
--
Total Expenses
7,241.5840
8,372.2090
4,939.8480
7,782.4000
2,658.4750
Net Income from Continuing & Discontinued Operation
-8,310.2120
-9,362.2170
-5,577.9260
-7,107.0820
-3,670.4020
Normalized Income
-8,266.2993
-9,323.5014
-5,589.9744
-8,399.1635
-3,553.0122
Interest Income
--
--
--
20
22.8490
Interest Expense
1,266.1130
1,236.3030
1,011.4920
1,223.4950
672.1910
Net Interest Income
-1,749.8750
-1,236.3030
-860.5850
-1,217.3080
-887.3420
EBIT
-7,007.9150
-8,092.1180
-4,563.2550
-5,880.6310
-2,986.0450
EBITDA
-6,367.6340
-7,401.2780
-3,910.8560
-5,090.0780
-2,588.5550
Reconciled Cost of Revenue
404.1660
166.5620
53.1900
45.4240
12.9100
Reconciled Depreciation
640.2810
690.8400
652.3990
790.5530
397.4900
Net Income from Continuing Operation Net Minority Interest
-8,310.2120
-9,362.2170
-5,577.9260
-7,107.0820
-3,670.4020
Total Unusual Items Excluding Goodwill
-51.6620
-64.5260
16.3280
1,757.9340
-159.7140
Total Unusual Items
-51.6620
-64.5260
16.3280
1,757.9340
-159.7140
Normalized EBITDA
-6,315.9720
-7,336.7520
-3,927.1840
-6,848.0120
-2,428.8410
Tax Rate for Calcs
0.0002
0.0004
0.0003
0.0003
0.0003
Tax Effect of Unusual Items
-7.7493
-25.8104
4.2796
465.8525
-42.3242
12/31/2020 - 2/25/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade